Remodeling of the tumor microenvironment via disrupting Blimp1+ effector Treg activity augments response to anti-PD-1 blockade
Abstract Background Accumulation of Foxp3+ regulatory T (Treg) cells in the tumor often represents an important mechanism for cancer immune evasion and a critical barrier to anti-tumor immunity and immunotherapy. Many tumor-infiltrating Treg cells display an activated phenotype and express the trans...
Enregistré dans:
| Auteurs principaux: | Michael L. Dixon, Lin Luo, Sadashib Ghosh, Jeffrey M. Grimes, Jonathan D. Leavenworth, Jianmei W. Leavenworth |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
BMC
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/30ce81d646da475cb6af87c87c5a8680 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
CD4+ effector T cells accelerate Alzheimer’s disease in mice
par: Jatin Machhi, et autres
Publié: (2021) -
Increased Frequency of CTLA-4 and PD-1 Expressing Regulatory T Cells and Basophils With an Activating Profile in Infants With Moderate-to-Severe Atopic Dermatitis Hypersensitized to Food Allergens
par: Agurtzane Bilbao, et autres
Publié: (2021) -
The TNF-α/TNFR2 Pathway: Targeting a Brake to Release the Anti-tumor Immune Response
par: Audrey Moatti, et autres
Publié: (2021) -
Impact of Graft-Resident Leucocytes on Treg Mediated Skin Graft Survival
par: Romy Steiner, et autres
Publié: (2021) -
“High Treg” Inflammations Promote (Most) Non-Hematologic Cancers While “Low Treg” Inflammations Promote Lymphoid Cancers
par: Elkoshi Z
Publié: (2020)